Mogollon-Torres FM, Rodríguez-Cruz LD, Zevallos-Cotrina AR, Diaz-Manchay RJ

Language: Spanish
References: 27
Page: 580-589
PDF size: 658.00 Kb.

ABSTRACT

Objective: to describe the clinical and epidemiologic characteristics of COVID-19 patients in telemonitoring at the first level of care. Materials and methods: descriptive, cross-sectional, retrospective research, with a non-probabilistic convenience sample of 332 records of patients suspected of SARS-CoV-2 from a primary health care center. The data was collected from the SISCOVID 19 platform, with prior permission from the institution, and the personal identification data was protected with codes. Results: of the population studied, they were women (58.73%), mean age 39 years, 31.02% wor-ked in service activities, 22.89% were housewives and 8.73% were health personnel. Hypertension (5.72%), obesity (3.31%) and cardiovascular disease (2.71%) were the most frequent comorbidities. 100.00% diagnosed with rapid test, 86.61% reported ha-ving home contact. Symptoms at the start of telemonitoring included: cough (56.02%) and sore throat (50.00%); 100% of cases received telephone follow-up, 25.00% longer than 16 days; the symptoms that lasted an average of 6 days were: headache (6.39%) and sore throat (5.92%); and the one that persisted the most was headache (6,385 ± 4,555 days). Most of the patients presented mild symptoms (67.77%). Conclusions: telemonitoring has great potential for the follow-up of patients in epidemic contexts, because it allows early detection of cases. Therefore, it reduces hospitalizations, redu-ces the risk of infection for health personnel and families, reduces follow-up operating costs, improves referral of complicated cases and allows education on preventive measures and treatment at home.

REFERENCES

1. World Health Organization. Clinical management of severe acute respiratory infection (‎‎‎SARI)‎‎‎ when COVID-19 disease is suspected: interim guidance. Washington D.C: World Health Organization; 2020.

2. World Health Organization. Infection prevention and control of epidemic- and pandemicprone acute respi-ratory diseases in health care. Washington D.C: World Health Organization; 2014.

3. Ticona-Huaroto C, Espinoza M, Eduardo Ticona E. COVID-19. El manejo ambulatorio durante la transmisión comunitaria intensa.An Fac med. 2020; 81(2):211-217. https://doi.org/10.15381/anales.v81i2.18406

4. Martínez-García M, Bal-Alvarado M, Santos-Guerra F, Ares-Rico R, Suárez-Gil R, Rodríguez-Álvarez A, et al. Telemedicina con telemonitorización en el se-guimiento de pacientes con COVID-19. Rev Clínica Española. 2020; 220(8):472-479. https://doi.org/10.1016/j.rce.2020.05.013

5. Ministerio de Sanidad. Documento técnico Manejo en atención primaria y domiciliaria del COVID-19. Madrid: Ministerio de Sanidad de España; 2020.

6. Franco-Babativa DC. Retos logísticos en salud asumidos por Bogotá para enfrentar el COVID-19. Bogotá: Universidad Militar Nueva Granada Facultad de Ingeniería; 2020.

7. Giovanella L, Vega R, Tejerina-Silva H, Acosta-Ramirez N, Parada-Lezcano M, Ríos G, et al. ¿Es la atención primaria de salud integral parte de la respuesta a la pandemia de Covid-19 en Latinoamérica? Trabalho, Educação e Saúde.2021; 19:1-428. https://doi.org/10.1590/1981-7746-sol00310

8. Ministerio de salud. Manual del SISCOVID: Sistema Integrado para COVID-19. Ministerio de salud del Perú; 2020.

9. Ministerio de salud. Directiva administrativa N° 293-MINSA/2020/DIGEP. “Directiva Administrativa que regula el trabajo remoto de salud (TRIS) para el personal de la salud y administrativo del Ministerio de Salud y Gobiernos Regionales”. Ministerio de salud del Perú; 2020.

10. Ministerio de Salud. Directiva administrativa N° 298-MINSA/2020/DGIEPS. Directiva administrativa que regula los procesos, registros y accesos a la información para garantizar el seguimiento integral de los casos sospechosos y confirmados de COVID-19 (SISTEMA INTEGRADO PARA COVID 19-SISCOVID-19). Ministerio de Salud del Perú; 2020.

11. Hernández-Sampiere R, Mendoza C. Metodología de la Investigación. Las rutas cuantitativa, cualitativa y mixta. México: McGraw-Hill Education; 2018.

12. Ministerio de Salud. Alerta epidemiológica 010-2020. Lima: Ministerio de Salud del Perú; 2020.

13. Ministerio de Salud. Directiva sanitaria 096 para el seguimiento clínico de personas afectadas por COVID-19 en Perú. Lima: Ministerio de Salud del Perú; 2020.

14. Ministerio de Salud. Ficha de reporte de prueba rápida – COVID-19. Ministerio de Salud del Perú; 2020

15. Kaur N, Gupta I, Singh H, Karia R, Ashraf A, Habib A, et al. Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis.SN Compr Clin Med 2020; 2:1048–1052. https://doi.org/10.1007/s42399-020-00393-y

16. Mash B. Primary care management of the coronavirus (COVID-19). South African Family Practice. 2020; 62(1):e1-e4. DOI: 10.4102/safp.v62i1.5115

17. Khamis-Ibrahim N. Epidemiologic surveillance for controlling Covid-19 pandemic: types, challenges and implications. Journal of Infection and Public Health. 2020; 13(11):1630-1638. https://doi.org/10.1016/j.jiph.2020.07.019

18. Defaz S, Escobar N, Ausay J, García C. Características Clínico-Epidemiológicas de pacientes COVID-19 atendidos en las unidades operativas del Distrito de Salud 05D06, Cantón Salcedo. Investigación & Desa-rrollo. 2020; 12(1):94-101.

19. Guzmán-Del Giudice OE, Lucchesi-Vásquez EP, Trelles-De Belaúnde M, Pinedo-Gonzales RH, Camere-Torrealva MA, Daly A, Pichilingue-Chagray JE. Características clínicas y epidemiológicas de 25 casos de COVID-19 atendidos en la Clínica Delgado de Lima. Rev Soc Peru Med Interna. 2020; 33(1):15-24. DOI: https://doi.org/10.36393/spmi.v33i1.506

20. Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinical and epidemiological characteristics of patients diagnosed with covid-19 in a tertiary care center in mexico city: a prospective cohort study. Rev Invest Clin. 2020; 72(3):165-177. DOI: 10.24875/RIC.20000211

21. Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, Lumbreras-Bermejo C, Ramos-Rincón JM, Roy-Vallejo E, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clin Esp (Barc). 2020; 220(8):480-494. https://doi.org/10.1016/j.rceng.2020.07.003

22. Llaro-Sánchez MK, Gamarra-Villegas BE, Campos-Correa KE. Características clínico-epidemiológicas y aná-lisis de sobrevida en fallecidos por COVID-19 atendidos en establecimientos de la Red Sabogal-Callao 2020. Horiz Med (Lima). 2020; 20(2):1-8. http://dx.doi.org/10.24265/horizmed.2020.v20n2.03

23. Giesen C, Diez-Izquierdo L, Saa-Requejo CM, Lopez-Carrillo I, Lopez-Vilela CA, Seco-Martinez A, et al. Epidemio-logical characteristics of the COVID-19 outbreak in a secondary hospital in Spain. Am J Infect Control.2020; 49(2):143-150. https://doi.org/10.1016/j.ajic.2020.07.014

24. Docherty B, Harrison EM, Green CA, Hardwickt HE, Pius R, Norman L, et al. Features of 20 133 UK Patients in Hospital With Covid-19 Using the ISARIC WHO Clinical Characterisation Protocol: Prospective Obser-vational Cohort Study. BMJ Clinical Research Ed. 2020; 369:1-12. https://doi.org/10.1136/bmj.m1985

25. Ticona-Huaroto C, Espinoza-Silva ME, Ticona-Chávez E. COVID-19. El manejo ambulatorio durante la trans-misión comunitaria intensa. An Fac med. 2020; 81(2):211-217.https://doi.org/10.15381/anales.v81i2.18406

26. Red Asistencial Lambayeque – EsSalud. Intercambio de experiencias, historias y buenas prácticas en Atención Primaria de Salud para enfrentar la pandemia de la COVID-19 – Perú. “Atención Primaria de la Salud: Redefiniendo el paradigma en el control de la COVID-19”. Red Asistencial Lambayeque Essalud.OPS-OMS; 2020.

27. Greenhalgh T, Choon KG, Car J. COVID-19: a remote assessment in primary care. BMJ. 2020; 368:1-5. https://doi.org/10.1136/bmj.m1182